omeprazole has been researched along with oxyntomodulin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tarui, S | 1 |
Beinborn, M; Ishida, H; Nagamatsu, S; Takahashi, S; Watanabe, K | 1 |
Breitschaft, A; Bækdal, TA; Hansen, CW; Navarria, A | 1 |
1 trial(s) available for omeprazole and oxyntomodulin
Article | Year |
---|---|
A randomized study investigating the effect of omeprazole on the pharmacokinetics of oral semaglutide.
Topics: Administration, Oral; Adult; Aged; Area Under Curve; Drug Interactions; Female; Glucagon-Like Peptides; Humans; Hypoglycemic Agents; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors | 2018 |
2 other study(ies) available for omeprazole and oxyntomodulin
Article | Year |
---|---|
[Progress of gastrin research--from gene to big gastrin N-terminal fragment].
Topics: Amino Acid Sequence; Chromatography; Gastric Mucosa; Gastrins; Glicentin; Glucagon; Glucagon-Like Peptides; Histamine; Humans; Molecular Sequence Data; Omeprazole; Peptide Fragments; Protein Conformation; Protein Precursors; Stomach Ulcer | 1990 |
Ménétrier's disease in a patient with Helicobacter pylori infection is linked to elevated glucagon-like peptide-2 activity.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Gastritis, Hypertrophic; Glucagon-Like Peptide 2; Glucagon-Like Peptides; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Minocycline; Omeprazole; Peptides; Remission Induction | 2005 |